2020
DOI: 10.36348/sjpm.2020.v05i03.003
|View full text |Cite
|
Sign up to set email alerts
|

Study of Hematological Parameters in End Stage Renal Disease Patients; Those on Regular Hemodialysis as Renal Replacement Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 0 publications
1
4
0
Order By: Relevance
“…Regarding mean corpuscular volume MCV, we found that the MCV mean value in the NDD-CKD group is 83.14 fl, and in the DD-CKD group is 85.18 fl compared with a mean MCV value of 90.49 fl in the control healthy group. This shows that normocytic anemia is the most prevalent type in our patients which is consistent with other studies (7) .…”
Section: Discussionsupporting
confidence: 94%
See 1 more Smart Citation
“…Regarding mean corpuscular volume MCV, we found that the MCV mean value in the NDD-CKD group is 83.14 fl, and in the DD-CKD group is 85.18 fl compared with a mean MCV value of 90.49 fl in the control healthy group. This shows that normocytic anemia is the most prevalent type in our patients which is consistent with other studies (7) .…”
Section: Discussionsupporting
confidence: 94%
“…Another study conducted in 2020 had found that the mean hemoglobin concentration in DD-CKD patients was 8.6 g/dl in pre-dialysis collected samples (7) . We found that hematocrit in the NDD-CKD group was ranging from 20.80 -47.50% with a mean value of 31.2%.…”
Section: Discussionmentioning
confidence: 98%
“…Chronic kidney disease (CKD) is an increasing public health issue with high incidence of morbidity and mortality that occur commonly throughout a worldwide [1]. CKD may be related with the progression of cardiovascular disease which is the important cause of morbidity and mortality in CKD patients [2] and constitutes greater burden of cost of care especially in developing countries [3]. According to the Kidney Disease Outcomes Quality Initiative (K/DOQI) CKD is defined as renal damage or when glomerular filtration rate (GFR) falls below 60 ml/min/1.73m 2 that lasts longer than three months [4].…”
Section: Introductionmentioning
confidence: 99%
“…In many cases, rates of kidney disease are determined by socioeconomic factors which leads to large disparities in the number of kidney failure patients [4]. Chronic renal failure (CRF) leads to high morbidity as well as high mortality, which needs special care in developing countries [5]. In fact, renal failure with its increasing prevalence, high costs for the treatment, and poor outcomes has become a global health problem [5].…”
Section: Introductionmentioning
confidence: 99%
“…Chronic renal failure (CRF) leads to high morbidity as well as high mortality, which needs special care in developing countries [5]. In fact, renal failure with its increasing prevalence, high costs for the treatment, and poor outcomes has become a global health problem [5]. There is a significant increase of early-stage chronic kidney disease (CKD) cases where the kidney function is lost, that leads to cardiovascular disease (CVD), and consequently causing premature death from failure [6].…”
Section: Introductionmentioning
confidence: 99%